Yunnan Institute of Population and Family Planning Research, Kunming, China 4

Size: px
Start display at page:

Download "Yunnan Institute of Population and Family Planning Research, Kunming, China 4"

Transcription

1 517259APH / Asia-Pacific Journal of Public HealthZhou et al research-article2014 Article Temporal Trends of Copper-Bearing Intrauterine Device Discontinuation: A Population-Based Birth-Cohort Study of Contraceptive Use Among Rural Married Women in China Asia-Pacific Journal of Public Health 2015, Vol. 27(2) APJPH Reprints and permissions: sagepub.com/journalspermissions.nav DOI: / aph.sagepub.com Jie Zhou, MMed 1,2, Xiaodong Tan, PhD 1, Xiangjing Song, MD 3, Kaining Zhang, MMed 2, Jing Fang, PhD 2, Lin Peng, MMed 3, Wencai Qi, MD 4, Zonghui Nie, MD 5, Ming Li, MD 6, Rui Deng, MMed 2, and Chaofang Yan, MMed 2 Abstract Copper-bearing intrauterine device (IUD) insertion for long-term contraceptive use is high in China, but there has been evidence that first-year discontinuation rate of copper-bearing IUD has also increased rapidly in recent years especially among rural married women. To investigate long-term use of copper-bearing IUD, the authors examined the 7-year temporal trends of copper-bearing IUD discontinuation in a population-based birth-cohort study among 720 rural married women in China, from 2004 to Women requesting contraception were followed-up twice per year after the insertion of IUD. The gross cumulative life table discontinuation rates were calculated for each of the main reasons for discontinuation as well as for all reasons combined. By the end of 7 years, 384 discontinuations were observed. With a stepped-up trend, the gross cumulative life table rate for discontinuation increased from (95% confidence interval = ) per 100 women by the first year to (95% confidence interval = ) per 100 women by the end of 7 years, which increased rapidly in the first 2 years after copper-bearing IUD insertion, flattened out gradually in the following 2 years, then increased again in the last 3 years. Among reported method failure, expulsion and side effects were the main reasons for discontinuation of the copper-bearing IUD but not pregnancy. Personal reasons, such as renewal by personal will had influenced copperbearing IUD use since the second year and should not be neglected. Based on this study, the temporal trends of copper-bearing IUD discontinuation was in a stepped-up trend in 7 years 1 Wuhan University, Wuhan, China 2 Kunming Medical University, Kunming, China 3 Yunnan Institute of Population and Family Planning Research, Kunming, China 4 Family Planning Centre of Yuanmou County in Yunnan Province, Yuanmou, China 5 Health Bureau of Yuanmou County, Yuanmou, China 6 Maternal and Child Care Service Centre of Yuanmou County, Yuanmou, China Corresponding Author: Jie Zhou, MMed, School of Public Health, Wuhan University, Wuhan, , China @163.com

2 NP2434 Asia-Pacific Journal of Public Health 27(2) after insertion. Both reported method failure (expulsion and side effect) and personal reason had effect on the discontinuation of copper-bearing IUD, but pregnancy was no more the most important reason affecting the use of copper-bearing IUD. Keywords copper-bearing intrauterine device, discontinuation, temporal trends, life table rates Introduction The intrauterine device (IUD) is one of the most widely used, reversible contraceptive methods in the world, and women living in China constitute about 70% of the 106 million global users. 1 As a long-lasting, flexible, safe, and reversible method, IUD is currently the most popular method of birth control in China, used by more than 40% of women of reproductive age in rural areas. 2,3 Previously, the most commonly used IUD in China was the stainless steel ring (SSR), which has been available since the 1950s. 4 With the introduction of the copper-bearing IUD in the early 1980s, together with evidence from many comparative studies that the SSR had much higher failure and expulsion rates, 5,6 the State Family Planning Commission decided to stop producing the SSR in The copper-bearing IUD had a long life span, for example, a copper T IUD continued to be effective for up to 20 years. 8 Copper-bearing IUD insertion for long-term use is high in China, but recently there has been evidence that copper-bearing IUD failure rate in China was also among the highest, and it has been shown that the first-year discontinuation rate for IUD was nearly 10%. 9,10 Since gynecologists practicing in China are seeing an increasing number of long-term copper-bearing IUD use, it is essential to explore the temporal tends of copper-bearing IUD discontinuation. The present study serves to provide a population-based temporal trend in the rates of copperbearing IUD discontinuation among rural married women from 2004 to 2012 in Yuanmou county of Yunnan, one of China s most populous provinces. The objectives of this study were 3-fold: (a) to investigate the temporal trend of copper-bearing IUD discontinuation as contraceptive use among rural married women for up to 7 years after insertion, (b) to investigate the continuation rate for up to 7 years of use, and (c) to determine the reason of copper-bearing IUD discontinuation for up to 7 years postinsertion. Methods Study Population and Recruitment This prospective population-based birth-cohort study was conducted by Kunming Medical University and family planning clinics in Yuanmou County of Yunnan province, China. Eligible participants were healthy rural married women, aged 18 to 45 years, with regular menstrual cycles between 24 and 42 days duration and a known date of the last menstrual period (LMP). Women needed to have a desire to use IUD as a long-term contraceptive method, accepted a copper-bearing IUD insertion from July 1, 2004 to June 30, 2005 in family planning clinics and hospital, and also were willing to participate in 2-times-per-year follow-up examination. Exclusion criteria included suspected or confirmed pregnancy, any episode of pelvic inflammatory or pelvic abscess in the 12 months preceding trial admission, sexually transmitted infection within the past 6 months, any evidence of sexually transmitted infection on clinical or laboratory examination during the initial examination, multiple sexual partners, known or suspected genital tract malignancy, cervical or uterine malformations, vaginal bleeding of unknown etiology, and multiple uterine fibroids associated with previous menstrual anomalies. In addition, women who were unsure about the date of their LMP (LMP needed for pregnancy risk assessment), were currently

3 Zhou et al NP2435 taking oral contraceptive pills, or had used spermicide, condom (even in cases of slippage or breakage), or other barrier method during their last sexual intercourse were excluded from the study. All women who satisfied the admission criteria gave written informed consent and were subsequently enrolled into the study. Women were asked to come for follow-up visits 2 times per year from 2005 to Women were also instructed to return for unscheduled visits if they had any problems. The clinics participating in this trial were open from Monday to Saturday, and acute care clinics were open in the evenings and at weekends, should an unscheduled visit be necessary. The copper-bearing IUDs used in this trial were all provided by the government, produced by certified enterprises/factories in China. China Food and Drug Administration had approved these copper-bearing IUDs. The validity periods of copper-bearing IUDs were more than 7 years. Details of Ethics Approval Ethics approval was given by the Institutional Review Board of the National Research Institute for Family Planning, Beijing. Written informed consent was obtained from all women participating in the study. Sampling Procedure The sample was based on a national cross-sectional survey of copper-bearing IUD use among rural married women in China. The multiphase stratified random cluster sampling method was applied in 4 major steps. First of all, Yunnan Province was randomly selected from the western provinces of China. Second, Yuanmou County was 1 of the 3 counties that was randomly selected from Yunnan Province. Third, in Yuanmou County, 3 townships were selected for the study. The central township, which is the official seat of a county government, and the remaining 2 were randomly sampled from the total number of townships in the country. Finally, based on the daily record of the prevalence of contraceptive use among women, at least 200 eligible women from each selected township were cluster sampled from the village. To take into account an estimated 20% refusal or loss to follow-up, 240 target women from each study site were initially randomly sampled. Follow-up Visits The initial visit included the recording of information regarding the date of the initial examination, age, medication use; date of onset of LMP, usual cycle length, and expected date of onset of next menstruation; and contraceptive history, including the use of contraception during the previous and current cycle. A pelvic examination was performed to determine whether there was any evidence of cervical or uterine infection. The follow-up visits were based on the daily clinical visit by the family planning administration and the information was taken from the medical record. Women could discontinue the study early at any time. Investigators discontinued any participation in cases of pelvic inflammatory disease, perforation, copper-bearing IUD displacement or expulsion, pregnancy, or high-grade cytological findings on the Papanicolaou screening test. In cases of pain, irregular bleeding, or heavy menstruation, the woman and the physician investigator could decide whether or not to continue the trial. Nonmedical reasons for discontinuation included failure to rely solely on copper-bearing IUD as a method of contraception, desire to become pregnant, a move out of the study area, and loss to follow-up. Measures The primary outcome measures were the gross cumulative life table discontinuation rates for each of the main reasons (reported method failure and personal reason) in every year. These were

4 NP2436 Asia-Pacific Journal of Public Health 27(2) determined by a positive high-sensitivity urine pregnancy test, by vaginal/abdominal ultrasound, and/or by personal report at the follow-up visit. Secondary outcome measures included cumulative life table continuation rates from up to 7 years after insertion. Analysis The data were collected on standard precoded duplicate forms at admission, follow-up, and final visits at the family planning clinic. The forms were sent to the Institute of Health Sciences of Kunming Medical University in Kunming, which was the coordinating centre responsible for the data management of the trial. The data were analyzed on a personal computer with the Statistical Package of Life Table Analysis (LTA, World Health Organization, Geneva, Switzerland). 11 Single decrement, gross cumulative life table discontinuation rates were calculated for each of the 3 main reasons (reported method failure, a desire to become pregnant, and personal reason) for annual discontinuation as well as for all reasons combined. Every year, gross cumulative life table discontinuation rates were computed with the corresponding 95% confidence interval. Results Demographics and Clinical Characteristics of Intrauterine Device Use After all inclusion/exclusion criteria were applied, a total of 720 women participated in the study between July 1, 2004 to June 30, 2005 in family planning institutions, clinics, or hospitals in 3 towns throughout Yuanmou County. Participants lost to follow-up before 7 years were included in the analysis up to the point when they were lost to follow-up. The baseline characteristics of these participants based on parity are shown in Table 1. The majority of copper-bearing IUD users had at least a secondary school education (53.75%). The outcome of the last pregnancy for most women users was vaginal delivery (74.03%), followed by induced abortion (13.99%) and abdominal delivery (9.16%). For nearly 50% of the participants, it was their first time to have copper-bearing IUD insertion, but more than 40% of the women had a second insertion and nearly 10% had 3 or more insertions. The 3 major types of copper-bearing IUD used by the women in this study were uterine-shaped Cu (32.08%), T Cu (21.67%), and active γ (20.56%). Discontinuation of Copper-Bearing Intrauterine Device by the End of 7 Years By the end of 7 years, 384 discontinuations had occurred. The main reasons for these discontinuations were as follows: reported method failure (184; including 115, 43, and 26 for expulsion, removals for bleeding/pain, and pregnancy, respectively), planning pregnancy (141), and renewal by personal will (59). In addition, 40.14% of the women were continuing copper-bearing IUD users at the end of 7 years, and 6.53% (47 cases) were not followed for a complete 7 years because of loss to follow-up (23) and because of the cutoff date of the study (study termination 24). Temporal Trends of 7 Years Copper-Bearing Intrauterine Device Discontinuation and Continuation The gross cumulative life table discontinuation rates are shown in Figure 1. These rates were calculated for each of the 2 main reasons (reported method failure, planning pregnancy, and renewal by personal will) for every year discontinuation as well as for all reasons combined. The gross cumulative discontinuation rates was (95% confidence interval [CI] = ) per 100 women in the first year. As with previous studies, rate of discontinuation was high

5 Zhou et al NP2437 Table 1. Baseline Demographics and Clinical Characteristics of the Copper-Bearing Intrauterine Device (IUD) Users Enrolled in the Study. a Participant Characteristics and History of IUD Use Total (N = 720) Age in years, mean ± SD ± 4.76 Education, n (%) Illiterate 2 (0.28) Primary 290 (40.28) Secondary 387 (53.75) High school 40 (5.55) College and above 1 (0.14) Result of the last pregnancy, n (%) Vaginal delivery 533 (74.03) Abdominal delivery 66 (9.16) Abortion 6 (0.83) Induced abortion 100 (13.90) Dislocated pregnancy 8 (1.11) Other 7 (0.97) History of IUD use, n (%) 1 time 339 (47.08) 2 times 302 (41.95) 3 times 73 (10.14) >3 times 6 (0.83) IUD type at present, n (%) Uterine-shaped Cu 231 (32.08) T Cu 156 (21.67) Active γ 148 (20.56) MLCu (8.19) AiMu MCu 61 (8.47) Ring Cu 39 (5.42) Other 26 (3.61) in the first year after insertion. But it was observed that the rate showed an upward trend in following years by this study. At the first 2 years, the gross cumulative discontinuation rates increased from (95% CI = ) per 100 women to (95% CI = ) per 100 women, in a gradually increasing trend. Then, it rose at a slower pace, just (95% CI = ) per 100 women for the third year and (95% CI = ) per 100 women for the fourth year. After that, it increased rapidly again; gross cumulative discontinuation rates for the fifth, the sixth, and the seventh year were (95% CI = ) per 100 women, (95% CI = ) per 100 women, and (95% CI = ) per 100 women, respectively. And the cumulative continuation rates were (95% CI = ) per 100 women at the end of 7 years; the rates for other years are shown in Table 2. The Main Reasons for Discontinuation All the reported reasons method failure, planning pregnancy, and renewal by personal will contributed to the gross discontinuation. But each of them had different temporal trends and contributed to the gross discontinuation in different period (shown in Figure 1). The cumulative rates of reported method failure were (95% CI = ) per 100 women and (95% CI = ) per 100 women in the first and the second year with a gradually

6 NP2438 Asia-Pacific Journal of Public Health 27(2) Figure 1. The cumulative discontinuation rate in 7 years. Table 2. Gross Cumulative 7 Years Continuation/Discontinuation Rates for IUD by Reason for Discontinuation per 100 Women. Reasons for Discontinuation Year Continuation (CI) All Reasons (CI) Reported Method Failure (CI) Planning Pregnancy (CI) Personal Reasons (CI) ( ) ( ) ( ) ( ) ( ) ( ) 0.52 ( ) 0.18 (0-0.52) ( ) ( ) ( ) 3.61 ( ) 0.18 (0-0.52) ( ) ( ) ( ) ( ) 1.16 ( ) ( ) ( ) ( ) ( ) 4.44 ( ) ( ) ( ) ( ) ( ) 7.48 ( ) ( ) ( ) ( ) ( ) ( ) Abbreviations: IUD, intrauterine device; CI, confidence interval. increasing trend, but it flattened out gradually from third year after copper-bearing IUD insertion. From the third to the seventh year, the cumulative failure rates of copper-bearing IUD only increased from (95% CI = ) per 100 women to (95% CI = ) per 100 women with a slow upward trend in 5 years. The cumulative rates of planning pregnancy and renewal by personal will were similar to each other. Neither planned pregnancy nor renewal by personal will occurred in the first year, but both of them appeared from the second year. The cumulative rates of planning pregnancy increased rapidly in the following years, from 0.52 (95% CI = ) per 100 women in the second year to (95% CI = ) per 100 women in the seventh year, which was extremely close to cumulative rates of IUD failure. The cumulative rates of renewal by personal will was at a low level until the fourth year, from 0.18 (95% CI = ) per 100 women to 1.16 (95% CI, ) per 100 women, and then increased in the last 3 years to reach (95% CI = ) per 100 women in the seventh year. The reported method failure included pregnancy, expulsion, and removal due to bleeding/ pain. Compared with other reasons, the cumulative rate for pregnancy was the lowest among 7 years and never more than 5 per 100 women (Figure 2). Expulsion was the most important reason for the reported method failure. The cumulative rates of expulsion soared in the first 2 years, 7.07

7 Zhou et al NP2439 Figure 2. The cumulative rate of intrauterine device failure in 7 years. (95% CI = ) per 100 women for the first year and (95% CI = ) per 100 women for the second year, and then it flattened out gradually since the third year. At the end of 7 years, it was up to (95% CI = ). Both the cumulative rates of pregnancy and removals due to bleeding/pain showed a slow rise. At first, the cumulative rate of pregnancy was higher than that of the removals due to bleeding/pain. And then, after 4 years, the cumulative rate of the removals due to bleeding/pain was higher than that of pregnancy. At the end of 7 years, the cumulative rate of pregnancy and removals due to bleeding/pain were up to 4.84 (95% CI = ) per 100 women and 6.27 (95% CI = ). Pregnancy was no more the most important reason of IUD failure. Discussion This study may be the first prospective population-based birth-cohort study to report the discontinuation of the copper-bearing IUD among married women in the rural area of China by following-up for 7 years. In addition, this study reports the gross cumulative life table rates for each of the 3 main reasons for every year discontinuation as well as for all reasons combined. The stepped-up trend of copper-bearing IUD discontinuation presented in this report was different from those reported in previous multicenter trials 12,13 and very few reported in more recent studies of IUDs, especially in China. The temporal trend of copper-bearing IUD discontinuation can be identified into 3 stages. First of all, in the first 2 years, the gross cumulative discontinuation rates increased in a gradually trend, reaching nearly 20 per 100 women in the end. As with previous and recent studies, 9,14-17 rates of discontinuation were high in the first 2 years after insertion. But in this population-based study, the rates of the first year caught up with the rates of second year in clinic-based study in the same period. However, all these studies indicate that early discontinuation of copper-bearing IUD use continues to be an important problem. Second, in the third and fourth years, the rates flattened out gradually. And it seems that the copperbearing IUD use implied satisfaction with the method. But after that, third, the rates increased rapidly again until the end of 7 years, which has seldom been reported in previous studies. In addition, compared with the previous study in China, 12 the cumulative continuation rate of copper-bearing IUD decreased faster than before. Our findings suggest that the temporal trend of copper-bearing IUD discontinuation has changed and has different characteristics in different period and women should receive counseling from family planning doctor and researchers with a focus on certain problems associated with IUD use.

8 NP2440 Asia-Pacific Journal of Public Health 27(2) Among these 3 reasons of copper-bearing IUD discontinuation, the reported method failure (including expulsion, removals due to bleeding/pain, and pregnancy) was often reported by other studies. 12,13,18 But neither planning pregnancy nor renewal by personal will was mentioned in recent studies, especially in China. Compared with the previous study, both the rates of planning pregnancy and personal reason were higher than those reported in Although we cannot show causality, the clear association of the increase in discontinuation rates with planned pregnancy and renewal by personal will of the copper-bearing IUD since the third year suggests that personal reasons were responsible for the increase of the discontinuation rate. Personal reasons had been reported by Rivera et al 20 in 1999, but this study only focused on planned pregnancy. In this study, we found that renewal of copper-bearing IUD by personal will since the second year would affect the formal use of copper-bearing IUD more and more significantly. The life span of copper-bearing IUD is reported more than 10 years, and it has a good overall performance and a longer life span than previously expected. 21 But renewal of copperbearing IUD by personal will occurred since the second year after the insertion, and was up to (95% CI = ) per 100 women in the seventh year. However, all previous copperbearing IUD studies indicate that early discontinuation (the first year after copper-bearing IUD insertion) of copper-bearing IUD use continues to be an important problem. Compared with women who continued use of copper-bearing IUD, the women who renewed copper-bearing IUD by personal will would face the same problem twice or more during the same period. Although reasons for variation in the willingness or ability of women to persist with this method are unclear, the reasons for discontinuation of copper-bearing IUD were not related to the method itself but were driven by user and family planning doctors. It suggests that personal reason had influenced copper-bearing IUD use seriously and should not be neglected in the future. Figure 1 displays the cumulative discontinuation rates of copper-bearing IUD use per 100 women due to these main reasons from 1 to 7 years after insertion. The top 3 failure outcomes included total failure of copper-bearing IUD use, planned pregnancy, and renewal by personal will. Furthermore, rate of expulsion was increased significantly. Actually, expulsion is not a medical complication caused by method itself. Other studies conducted in China revealed that expulsion rates vary from 0.7 to 6.4 in the first year of copper-bearing IUD use, which were similar to the results of this study. Some studies reported that expulsion was more likely to happen among young women and the women who have not had children. 25,26 and the people in the study were married but 40% of them were younger than 25 years. Proper performance and skill of providers at placement of copper-bearing IUD in the uterine cavity has been shown to be associated with failure of copper-bearing IUD use. 27 If providers have not correctly placed a copperbearing IUD up to the top of the uterus, expulsion and downward dislocation can occur. This indicates that providers should be able to carefully measure position and size of the uterine cavity, and also choose a matched size of copper-bearing IUD for clients. During the study period, there were more than 10 types of copper-bearing IUD in Yuanmou County, but many providers reported that only 1 or 2 sizes of IUD for each type were available. Therefore, improper choice of copper-bearing IUD size may be an important contributing factor that can lead to the high rate of copper-bearing IUD expulsion. This study suggests that more studies focusing on the expulsion of copper-bearing IUD are needed in the future. Although this study demonstrates the efficacy of copper-bearing IUD, it is not without limitations. This was an observational study, and thus participants were not randomized to the type of copper-bearing IUD. Second, the main limitations of this analysis stem from the narrow range of available data. The birth cohort came from only single one county. Third, we did not perform any statistical tests among the different type of copper-bearing IUD because there were significantly more than 10 types of copper-bearing IUD enrolled in this study, making statistical tests among these groups difficult. This report therefore provides a general sense of how rural married women tolerate copper-bearing IUD as a long-term contraceptive.

9 Zhou et al NP2441 Conclusion Based on this study, the temporal trend of copper-bearing IUD discontinuation was in a steppedup manner over 7 years after insertion. The gross cumulative life table discontinuation rates for each of the 3 main reasons (reported method failure, a desire to become pregnant, and personal reason) as well as for all reasons combined had all increased for the long time use. Both reported method failure (expulsion and side effect) and personal reason had an effect on the discontinuation of copper-bearing IUD, but pregnancy was no more the most important reason that affected the use of copper-bearing IUD. Acknowledgments We acknowledge the diligent work of all family planning service providers who completed the follow-up visit in 7 years and collected data in the field. We thank Drs Junjie Li, Hao Luo, and Dong Jun for their invaluable expertise on clinical operation of intrauterine device insertion and data analyses. Last but not least, we appreciate the time and support of all participants. Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the National Research Program for the Tenth Five-Year Plan on Science and Technology (No. 2004BA720A31) and the Research Program of Scientific Research Funds of Education Department of Yunnan Province (No. 2010Y209). References 1. Ali MM, Sadler RK, Cleland J, Ngo TD, Shah IH. Long-Term Contraceptive Protection, Discontinuation and Switching Behaviour: Intrauterine Device (IUD) Use Dynamics in 14 Developing Countries. London, England: World Health Organization and Marie Stopes International; Bilian X. Chinese experience with intrauterine devices. Contraception. 2007;75(6 suppl):s31-s Gupta S, Kirkman R. Intrauterine devices update on clinical performance. Obstet Gynaecol. 2002;4: MacDonald TL, Gerscovich EO, McGahan JP, Fogata M. The Chinese ring: a contraceptive intrauterine device. J Ultrasound Med. 2006;25: State Family Planning Commission of China. A Clinical Trial of Three Commonly Used IUDs. Condensed Summary of Family Planning Scientific Research Results During the Sixth Five-Year Plan. Beijing, China: State Family Planning Commission of China; Gao J, Shen H, Zheng S, et al. A randomized comparative clinical evaluation of the steel ring, the VCu200 and the TCu220c IUDs. Contraception. 1986;33: Khanna J, Maurice J, eds. WHO HRP Department of Reproductive Health and Research China to upgrade its IUD technology. Prog Reprod Health Res. 2002;60: Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception. 2007;75(6 suppl):s70 S Zhang A, Wang A, Lai Y. Study on active γ type II intrauterine device. Chin J Fam Plann. 2011;19: Zhang KN, Wu SC, Peng L, et al. Epidemiologic study on IUD use and failure in nine provinces of China. Chin J Fam Plann. 2007;11: LTA Survival Analysis. Geneva, Switzerland: World Health Organization; Fang K, Chen J, Wu M, et al. Comparison of the performances of three type of IUD up to eight years. Chin J Fam Plann. 1994;9:19-61.

10 NP2442 Asia-Pacific Journal of Public Health 27(2) 13. Li Q. Utilization on B-ultrosonography in 10 years follow-up to women laid up IUDs. Mod Prev Med. 1999;26: Wu W. Comparison of the performances of three type of IUD up to two years. Mod Med. 2010;16(28): Wu S. Comparison of the performances of TCu-380A, γ-iud and MLCu375 up to three years. Mod Med Health Care. 2005;17: Ying Y, Wang M, Yang Y. Analysis of the performances of copper-bearing IUD. Yunnan Med. 2003;6: Yang Y, Dong G, Pan L. Comparison of the performances of four type of IUD. Chin J Fam Plann. 1999;47: Wu J, Zuo S. Clinical study for comparison of the performances of MLCu375SL and Tcu200C up to ten years. Reprod Contracept. 1999;19: Fang K, Cheng J, Wu M, et al. A multicentre comparative clinical study of three types of IUD (ten years follow-up). Reprod Contracept. 1996;16: Rivera R, Chen-Mok M, McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. Contraception. 1999;60: Bhattoa HP, Ganacharya S, Batár I. A decade of experience with TCu200. Adv Contracept. 2001;15: Fang K, Wu M, Cheng J, et al. A ten-year comparative multicenter study of three homemade intrauterine device in China. Reprod Contracept. 1996;16: Zhuang L, Yang B, Yuan H, et al. A study on copper γ-shaped intrauterine device. J Fam Plann China. 1994;2: Wang D, Altmann DR. IUD expulsion and its socio-demographic determinants in China. Reprod Contracept. 2002;13: Sivin L, el Mahgoub SE, McCarthy T, et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg-20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception. 1990;42: Tang W, Liu S. Complications and treatment of intrauterine device. J Pract Obstet Gynecol. 2001;17: Zhang C, Cheng X, Peng H, et al. A clinical analysis on dislocation and contraceptive failure of four common intrauterine devices. J Clin Ultrasonic Med. 2003;5:

1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S.

1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S. 1 2 1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S. The contraceptive action of all IUDs is mainly in the uterine cavity. The major effect

More information

2

2 1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive

More information

Emergency Contraception THE FACTS

Emergency Contraception THE FACTS Emergency Contraception Quick Facts What is it? Emergency contraception is birth control that you use after you have had unprotected sex--if you didn t use birth control or your regular birth control failed.

More information

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system) FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system) Mirena does not protect against HIV infection (AIDS) and other sexually transmitted infections

More information

Review of IUCD Complications: Lessons from CAT. Dr FG Mhlanga CAT Meeting 24 September 2016

Review of IUCD Complications: Lessons from CAT. Dr FG Mhlanga CAT Meeting 24 September 2016 Review of IUCD Complications: Lessons from CAT Dr FG Mhlanga CAT Meeting 24 September 2016 INTRODUCTION The intrauterine device (IUD) is a reliable long term reversible, cost-effective,easy to use and

More information

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Simplifying Vide Contraception University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Background Objectives At the conclusion of this presentation participants will be able

More information

What s New in Adolescent Contraception?

What s New in Adolescent Contraception? What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent

More information

CHINA STUDY. Friendly Collaboration And Fruitful Achievement. Introduction

CHINA STUDY. Friendly Collaboration And Fruitful Achievement. Introduction CHINA STUDY Friendly Collaboration And Fruitful Achievement Some Experiences and Understandings of the Research Work on the Billings Ovulation Method used in Shanghai, China by: Dr. Zhang De-wei, Advisor-

More information

Intrauterine Devices and Pelvic Inflammatory Disease: Dispelling the Myth. Dr Amy Moten SHine SA Co-authors: Dr Richelle Douglas; Dr Alison Creagh SHQ

Intrauterine Devices and Pelvic Inflammatory Disease: Dispelling the Myth. Dr Amy Moten SHine SA Co-authors: Dr Richelle Douglas; Dr Alison Creagh SHQ Australasian Sexual Health Conference Adelaide, November 14-16 Intrauterine Devices and Pelvic Inflammatory Disease: Dispelling the Myth Dr Amy Moten SHine SA Co-authors: Dr Richelle Douglas; Dr Alison

More information

Contraception and gynecological pathologies

Contraception and gynecological pathologies 1 Contraception and gynecological pathologies 18 years old, 2 CMI normal First menstruation at 14 years old Irregular (every 2/3 months), painful + She does not need contraception She is worried about

More information

Zurich Open Repository and Archive

Zurich Open Repository and Archive University of Zurich Zurich Open Repository and Archive Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2008 Partial and complete expulsion of the Multiload 375 IUD and the levonorgestrel-releasing

More information

Instruction for the patient

Instruction for the patient WS 4 Case 3 STI and IUD Your situation Instruction for the patient You are 32 years old, divorced and have one child; you have just started a new relationship You underwent surgical resection of the left

More information

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S. Mirena is the #1 prescribed IUD * in the U.S. Welcome to Mirena The Mirena Handbook: A Personal Guide to Your New Mirena *Intrauterine Device Supported by 2015-2016 SHS data INDICATIONS FOR MIRENA Mirena

More information

The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that

The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that The following lesson on contraception (birth control) is not intended to infer that you will be sexually active as a teen. This is information that may be used in the future Abstinence Choosing not to

More information

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use 3:45 4:30 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial

More information

الحمد هلل رب العالمين والصالة والسالم علي محمد الصادق الوعد األمين اللهم أخرجنا من ظلمات الجهل والوهم إلى نور المعرفة والعلم..

الحمد هلل رب العالمين والصالة والسالم علي محمد الصادق الوعد األمين اللهم أخرجنا من ظلمات الجهل والوهم إلى نور المعرفة والعلم.. الحمد هلل رب العالمين والصالة والسالم علي محمد الصادق الوعد األمين اللهم أخرجنا من ظلمات الجهل والوهم إلى نور المعرفة والعلم.. سيدنا 11/6/2013 1 Goals of Family Planning services : 1- Enable women and

More information

Contraception for Adolescents: What s New?

Contraception for Adolescents: What s New? Contraception for Adolescents: What s New? US Medical Eligibility Criteria for Contraceptive Use Kathryn M. Curtis, PhD Division of Reproductive Health, CDC Expanding Our Experience and Expertise: Implementing

More information

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines 1. Summary statement of the proposal for inclusion LNG-IUS is an effective contraceptive;

More information

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: Review Article ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com A REVIEW ON INTRAUTERINE DEVICES Boddu Venkata Komali* 1, M. Kalyani

More information

the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to

the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to your guide to Helping you choose the method of contraception that s best for you IUD IUD the e IUD IU IUD the IUD 2 3 The intrauterine device (IUD) An IUD is a small plastic and copper device that s put

More information

A PROSPECTIVE RANDOMIZED STUDY OF THE COPPER 7, MULTILOAD Cu 250 AND COPPER 220C IUDS IN SINGAPORE

A PROSPECTIVE RANDOMIZED STUDY OF THE COPPER 7, MULTILOAD Cu 250 AND COPPER 220C IUDS IN SINGAPORE A PROSPECTIVE RANDOMIZED STUDY OF THE COPPER 7, MULTILOAD Cu 250 AND COPPER 220C IUDS IN SINGAPORE TG McCarthy LSLim S M M Karim S S Ratnam Department of Obstetrics and Gynaecology National University

More information

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables LONG-ACTING REVERSIBLE CONTRACEPTION Summary Tables Bridging the Divide: A Project of the Jacobs Institute of Women s Health June 2016 Table 1. Summary of LARC Methods Available Years Since Effective Copper

More information

East Asia Forum Economics, Politics and Public Policy in East Asia and the Pacific

East Asia Forum Economics, Politics and Public Policy in East Asia and the Pacific Contraception, a family planning imperative 7th May, 2013 Authors: Baochang Gu, Renmin University, and Yan Che, SIPPR East Asia Forum Regulating childbearing through contraception, particularly via modern

More information

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common 4:15 5 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial

More information

Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community

Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community Reproductive Health 2012 September 21, 2012 David Turok, MD/MPH Objectives Communicate to colleagues the reduction

More information

The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings.

The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings. The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings Counseling Cards Checklist to be reasonably sure a woman is not pregnant

More information

BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018

BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018 BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018 Introduction Bleeding with contraception may lead to discontinuation and possible unintended pregnancy What

More information

Extended use of intrauterine devices: How long can we go?

Extended use of intrauterine devices: How long can we go? Extended use of intrauterine devices: How long can we go? Justine P. Wu, MD, MPH Sarah Pickle, MD Rutgers Robert Wood Johnson Medical School Department of Family Medicine & Community Health Disclosures

More information

Product Information. Confidence that lasts

Product Information. Confidence that lasts Confidence that lasts What is Mirena? Inhibition of sperm motility and function inside the uterus and the fallopian tubes, preventing fertilization (Videla-Rivero et al. 1987). Section of system Levonorgestrel

More information

Impact of Delivery Types on Women s Postpartum Sexual Health

Impact of Delivery Types on Women s Postpartum Sexual Health Reproduction & Contraception (2003) 14 (4):237~242 Impact of Delivery Types on Women s Postpartum Sexual Health Huan-ying WANG 1, Xiao-yang XU 2, Zhen-wei YAO 1, Qin ZHOU 1 Key words: postpartum; sexual

More information

VCHIP LARC Needs Assessment Survey

VCHIP LARC Needs Assessment Survey VCHIP LARC Needs Assessment Survey Demographics 1. How many have you been in practice (post-training)? Choose one of the following answers 0-5 6-10 11-15 16-20 21 or more 2. What are your professional

More information

Review of the application of levonorgestrel releasing implant for inclusion of the WHO Model List of Essential Medicines

Review of the application of levonorgestrel releasing implant for inclusion of the WHO Model List of Essential Medicines Review of the application of levonorgestrel releasing implant for inclusion of the WHO Model List of Essential Medicines The application is submitted by the Geneva Foundation for Medical Education and

More information

Family Planning UNMET NEED. The Nurse Mildred Radio Talk Shows

Family Planning UNMET NEED. The Nurse Mildred Radio Talk Shows Family Planning UNMET NEED The Nurse Mildred Radio Talk Shows TOPIC 9: IUD/COIL Guests FP counsellor from MSU, RHU& UHMG Nurse Mildred Nurse Betty Objectives of the programme: To inform listeners about

More information

2

2 1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive

More information

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit What We Plan To Do Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC) Explain

More information

Management of Emergency Contraception (EC)

Management of Emergency Contraception (EC) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Management of Emergency Contraception (EC) The risks and benefits of an IUD or oral EC should be discussed and documented (see appendix). Reasonable measures

More information

FIGO and Prevention of Unsafe Abortion LARC and PM for PAC

FIGO and Prevention of Unsafe Abortion LARC and PM for PAC FIGO and Prevention of Unsafe Abortion LARC and PM for PAC Dr. Anibal Faundes Second Regional Francophone West Africa PAC Meeting: Strengthening Postabortion Family Planning Saly, Senegal, October 6-11,

More information

BRIEF REPORTS. Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH

BRIEF REPORTS. Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH BACKGROUND AND OBJECTIVES: Providing long-acting reversible contraception

More information

Long-Acting Reversible Contraception: The Contraceptive CHOICE Project

Long-Acting Reversible Contraception: The Contraceptive CHOICE Project Long-Acting Reversible Contraception: The Contraceptive CHOICE Project Jeffrey F. Peipert, M.D., Ph.D. Vice Chair of Clinical Research Robert J. Terry Professor Department of Obstetrics & Gynecology Washington

More information

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises

More information

Contraceptives. Kim Dawson October 2010

Contraceptives. Kim Dawson October 2010 Contraceptives Kim Dawson October 2010 Objectives: You will learn about: The about the different methods of birth control. How to use each method of birth control. Emergency contraception What are they?

More information

Transcervical Sterilization

Transcervical Sterilization Q UESTIONS & ANSWERS A BOUT Transcervical Sterilization A New Choice in Permanent Birth Control Choosing a Birth Control Method Women and their partners now have more birth control choices than ever. How

More information

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data DIALYSIS Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 7 to 14 Analysis From Henan Peritoneal Dialysis Registry data Xiaoxue Zhang, 1 Ying Chen, 1,2 Yamei Cai, 1 Xing Tian,

More information

Key words: Contraception, Copper T380A, Discontinuation.

Key words: Contraception, Copper T380A, Discontinuation. Discontinuation Rates among Women Using either the Combined Oral Contraceptive Pills or an Intrauterine Contraceptive Device for Contraception: A Comparative Study Ehab Al-Rayyan MD*, Zakarya Bani Meri

More information

Medical Eligibility for Contraception Use

Medical Eligibility for Contraception Use Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist

More information

UNINTENDED PREGNANCY BY THE NUMBERS

UNINTENDED PREGNANCY BY THE NUMBERS FACT SHEET UNINTENDED PREGNANCY BY THE NUMBERS A look at Kenya Summary This fact sheet summarizes data collated during the development of the STEP UP Country Profile Report on Unintended Pregnancies for

More information

Levonorgestrel Intrauterine Device

Levonorgestrel Intrauterine Device CHAPTER 11 Levonorgestrel Intrauterine Device Key Points for Providers and Clients y Long-term pregnancy protection. Very effective for 5 years, immediately reversible. yinserted into the uterus by a specifically

More information

Levosert levonorgestrel 20mcg/24hour intrauterine device

Levosert levonorgestrel 20mcg/24hour intrauterine device Levosert levonorgestrel 20mcg/24hour intrauterine device Verdict: Formulary inclusion: Formulary category: Restrictions: Reason for inclusion: Link to formulary: Link to medicine review summary: Levosert

More information

Contraceptive Technology and Reproductive Health Series: Barrier Methods Post-test

Contraceptive Technology and Reproductive Health Series: Barrier Methods Post-test Contraceptive Technology and Reproductive Health Series: Barrier Methods Post-test Section I: Overview of Barrier Methods 1. The following are statements regarding all barrier methods. Please indicate

More information

Reproductive health research at WHO

Reproductive health research at WHO Reproductive health research at WHO Paul F.A. Van Look, MD PhD Department of Reproductive Health and Research World Health Organization Geneva, 11 March 2004 PVL_GE_StudCourse_MAR04/1 Health is a state

More information

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE Contraception Choices: An Evidence Based Approach Case Study Approach Susan Hellier PhD, DNP, FNP-BC, CNE Objectives Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC)

More information

Bursting Pelvic Inflammatory Disease.

Bursting Pelvic Inflammatory Disease. www.infertiltysolutionsng.info/blog Disclaimer The information in this book is provided for educational purposes only and is not intended to treat, diagnose or prevent any disease. The information in this

More information

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures LARC: Long Acting Reversible Contraception Disclosures I have no relevant financial disclosures Jennifer Kerns, MD, MPH Assistant Professor, UCSF Obstetrics, Gynecology and Reproductive Sciences San Francisco

More information

Acute Salpingitis. Fallopian Tubes. Uterus

Acute Salpingitis. Fallopian Tubes. Uterus Acute Salpingitis Introduction Acute salpingitis is a type of infection that affects the Fallopian tubes. The Fallopian tubes carry eggs from the ovaries to the uterus. Acute salpingitis is one of the

More information

Social Franchising as a Strategy for Expanding Access to Reproductive Health Services

Social Franchising as a Strategy for Expanding Access to Reproductive Health Services Social Franchising as a Strategy for Expanding Access to Reproductive Health Services A case study of the Green Star Service Delivery Network in Pakistan Background Pakistan has a population of 162 million

More information

Nelly Mugo, MBChB, MMed, MPH Kenya Medical Research Institute. May 2015

Nelly Mugo, MBChB, MMed, MPH Kenya Medical Research Institute. May 2015 Nelly Mugo, MBChB, MMed, MPH Kenya Medical Research Institute May 2015 Outline Rationale for the trial Design and objectives Contraceptive methods to be evaluated Study population and follow-up Potential

More information

Expanding Access to Injectable Contraception Geneva, June 2009

Expanding Access to Injectable Contraception Geneva, June 2009 Bangladesh Experience in Expanding the Delivery of Injectable Contraception A brief overview Presentation at Expanding Access to Injectable Contraception Geneva, 15-17 June 2009 Dr S. Thapa Reproductive

More information

Risk factors for IUD failure: results of a large multicentre case control study

Risk factors for IUD failure: results of a large multicentre case control study Human Reproduction Vol.21, No.10 pp. 2612 2616, 2006 Advance Access publication June 14, 2006. doi:10.1093/humrep/del208 Risk factors for IUD failure: results of a large multicentre case control study

More information

Understanding the Pattern of Contraceptive Discontinuation in India

Understanding the Pattern of Contraceptive Discontinuation in India Understanding the Pattern of Contraceptive Discontinuation in India Kiran Agrahari 1 Introduction The use of contraception among currently married women in India has increased from 41 percent in 1992-93

More information

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Executive Board of the United Nations Development Programme and of the United Nations Population Fund United Nations Executive Board of the United Nations Development Programme and of the United Nations Population Fund Distr.: General 9 April 2010 Original: English DP/FPA/DCP/PRK/5 Annual session 2010

More information

Immediate Postpartum Long-Term Reversible Contraception (LARC) Bethany Berry, CNM, MSN and Alyssa Givens, MSN, RN

Immediate Postpartum Long-Term Reversible Contraception (LARC) Bethany Berry, CNM, MSN and Alyssa Givens, MSN, RN Immediate Postpartum Long-Term Reversible Contraception (LARC) Bethany Berry, CNM, MSN and Alyssa Givens, MSN, RN Disclosures O Bethany Berry CNM is a Nexplanon trainer with Merck O Alyssa Givens, RN has

More information

Postpartum LARC. (Long Acting Reversible Contraception) NURSING EDUCATION

Postpartum LARC. (Long Acting Reversible Contraception) NURSING EDUCATION Postpartum LARC (Long Acting Reversible Contraception) NURSING EDUCATION What is LARC Long-acting reversible contraception (LARC) methods include the intrauterine device (IUD) and the birth control implant.

More information

The Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH

The Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH The Doctor Is In Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH Contraception Resources from the CDC: 2016 U.S. Medical Eligibility Criteria

More information

International Federation of Gynecology and Obstetrics

International Federation of Gynecology and Obstetrics International Federation of Gynecology and Obstetrics THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION

More information

WHAT ARE CONTRACEPTIVES?

WHAT ARE CONTRACEPTIVES? CONTRACEPTION WHAT ARE CONTRACEPTIVES? Methods used to prevent fertilization *Also referred to as birth control methods With contraceptives, it is important to look at what works for you and your body.

More information

prevalence was 13.8% among females

prevalence was 13.8% among females 1 2 3 1. Woldeamanuel YW et al. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of communitybased studies involving 6 million participants. J Neurol

More information

Bursting Pelvic Inflammatory Disease.

Bursting Pelvic Inflammatory Disease. www.infertiltysolutionsng.info/blog Disclaimer The information in this book is provided for educational purposes only and is not intended to treat, diagnose or prevent any disease. The information in this

More information

A Teacher s Guide Sexually

A Teacher s Guide Sexually sue 3. Grades 9-12 : Issue 3. milk. ed every year. ow stopthesilence TeenZine ol, even once, can Grades 9-12 : Issue 3. men who don't use me pregnant. s. chlamydia.,ghest can among 15 to Contraceptives

More information

Zurich Open Repository and Archive

Zurich Open Repository and Archive University of Zurich Zurich Open Repository and Archive Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2008 Comparison of two procedures for routine IUD exchange in women with positive

More information

Contraception & HIV Still searching for answers after >2 decades

Contraception & HIV Still searching for answers after >2 decades Contraception & HIV Still searching for answers after >2 decades R Scott McClelland, MD, MPH University of Washington Inter CFAR Symposium on HIV Research in Women September 20 th 2012 Overview Global

More information

Contraception for Women and Couples with HIV. Knowledge Test

Contraception for Women and Couples with HIV. Knowledge Test Contraception for Women and Couples with HIV Knowledge Test Instructions: For each question below, check/tick all responses that apply. 1. Which statements accurately describe the impact of HIV/AIDS in

More information

Same-Day Access to Highly Effective Reversible Contraception: Moving from Plan B to Happily Ever After

Same-Day Access to Highly Effective Reversible Contraception: Moving from Plan B to Happily Ever After Same-Day Access to Highly Effective Reversible Contraception: Moving from Plan B to Happily Ever After Eleanor Bimla Schwarz, MD, MS Director, Women s Health Services Research Unit Center for Research

More information

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014 Contraception Tami Allen, RNC OB, MHA Robin Petersen, RN, MSN Perinatal Clinical Nurse Specialist Objectives Discuss the impact of unintended pregnancy in the United States Discuss the risks and benefits

More information

Information for Informed Consent for Insertion of a Mirena IUD

Information for Informed Consent for Insertion of a Mirena IUD Information for Informed Consent for Insertion of a Mirena IUD What is an IUD (intrauterine Device)? An intrauterine device (IUD) is a plastic device that is placed into your uterus to prevent pregnancy.

More information

Notes to Teacher continued Contraceptive Considerations

Notes to Teacher continued Contraceptive Considerations Abstinence a conscious decision to refrain from sexual intercourse 100% pregnancy will not occur if close contact between the penis and vagina does not take place. The risk of a number of STDs, including

More information

Power Point Use in EBPs. CAPP & PREP Learning Community May 15, 2018

Power Point Use in EBPs. CAPP & PREP Learning Community May 15, 2018 Power Point Use in EBPs CAPP & PREP Learning Community May 15, 2018 Objectives Best practices for power point use Why use power point for EBP delivery Examples: the Good, the Bad and the Ugly Recommendations

More information

The number of women using long-acting reversible

The number of women using long-acting reversible Long-acting reversible contraception: Who, what, when, and how This review provides practical tips and dispels some common misconceptions about these devices, which have higher rates of patient satisfaction

More information

Chapter 7 Infertility, Contraception, and Abortion

Chapter 7 Infertility, Contraception, and Abortion Chapter 7 Infertility, Contraception, and Abortion Infertility Incidence Affects about 10% to 15% of reproductive-age population Subfertility: prolonged time to conceive Sterility: inability to conceive

More information

A systematic review of some of the side effects of copper T380 intrauterine contraceptive device

A systematic review of some of the side effects of copper T380 intrauterine contraceptive device A systematic review of some of the side effects of copper T380 intrauterine contraceptive device Ahmed Nehad Ahmed Hatem Askalani IAMANEH Scholarship Reproductive Health Research Course Geneva, 2006 Introduction

More information

Family Planning and Sexually Transmitted. Infections, including HIV

Family Planning and Sexually Transmitted. Infections, including HIV Infections, including HIV Family Planning and Sexually Transmitted Introduction To protect themselves, people need correct information about sexually transmitted infections (STIs), including HIV. Women

More information

Sexual and reproductive health research at WHO

Sexual and reproductive health research at WHO Sexual and reproductive health research at WHO Paul F.A. Van Look, MD PhD Department of Reproductive Health and Research World Health Organization Geneva, 4 March 2005 05_GE_StudCourse_MAR/1 Health is

More information

Contraceptive Updates and Recommendations

Contraceptive Updates and Recommendations Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,

More information

Contraceptive Updates and Recommendations

Contraceptive Updates and Recommendations Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,

More information

Birth Control Options Chart

Birth Control Options Chart Hormonal Methods Birth control pills also known as mini-pills 91-99% A daily pill containing hormones that stops you from ovulating. There are combination estrogen or progestin-only (mini-pill) options.

More information

Indonesia and Family Planning: An overview

Indonesia and Family Planning: An overview Indonesia and Family Planning: An overview Background Indonesia comprises a cluster of about 17 000 islands that fall between the continents of Asia and Australia. Of these, five large islands (Sumatra,

More information

Unintended Pregnancy in U.S. The Importance of LARC: What have We Learned? Long-acting Reversible Contraception (LARC)

Unintended Pregnancy in U.S. The Importance of LARC: What have We Learned? Long-acting Reversible Contraception (LARC) Unintended Pregnancy in U.S. The Importance of LARC: What have We Learned? Colleen McNicholas, DO, MSCI Department of Obstetrics & Gynecology Washington University in St. Louis School of Medicine Over

More information

Appendix 1. Supplementary Methods

Appendix 1. Supplementary Methods Appendix 1. Supplementary Methods The report on one high-quality study 34 provided only estimates of associations between cervical cancer incidence and IUD use for less than 5 years (versus never) and

More information

CHAPTER 5 FAMILY PLANNING

CHAPTER 5 FAMILY PLANNING CHAPTER 5 FAMILY PLANNING The National Family Welfare Programme in India has traditionally sought to promote responsible and planned parenthood through voluntary and free choice of family planning methods

More information

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial A Multi-Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence and Contraceptive Benefits in Women using Depot Medroxyprogesterone

More information

CHAPTER II CONTRACEPTIVE USE

CHAPTER II CONTRACEPTIVE USE CHAPTER II CONTRACEPTIVE USE In a major policy and programmatic shift in April 1996, India s National Family Welfare Programme was renamed the Reproductive and Child Health Programme. This programme enunciated

More information

Does Policy Relaxation Increase Contraceptive Flexibility: Short-Acting Contraceptive Use in China

Does Policy Relaxation Increase Contraceptive Flexibility: Short-Acting Contraceptive Use in China Does Policy Relaxation Increase Contraceptive Flexibility: Short-Acting Contraceptive Use in China (Draft version) Xingshan Cao Department of Sociology University of Toronto 725 Spadina Avenue Toronto,

More information

Click to edit Master title style. Unintended Pregnancy: Prevalence. Unintended Pregnancy: Risk Groups. Unintended Pregnancy: Consequences 9/23/2015

Click to edit Master title style. Unintended Pregnancy: Prevalence. Unintended Pregnancy: Risk Groups. Unintended Pregnancy: Consequences 9/23/2015 The Role of Childhood Violence, Self-esteem and Depressive Symptoms on Inconsistent Contraception Use among Young, Sexually Active Women Deborah B. Nelson, PhD Associate Professor Unintended Pregnancy:

More information

F REQUENTLY A SKED Q UESTIONS. fallopian tube instead of the uterus), constant pelvic pain, and other problems.

F REQUENTLY A SKED Q UESTIONS. fallopian tube instead of the uterus), constant pelvic pain, and other problems. PID can be treated and cured with Pelvic antibiotics. If left untreated, PID can lead to serious problems like infertility (not being able to get pregnant), ectopic pregnancy (pregnancy in the Inflammatory

More information

38 OBG Management August 2012 Vol. 24 No. 8 obgmanagement.com

38 OBG Management August 2012 Vol. 24 No. 8 obgmanagement.com FIGURE 1 Copper intrauterine device displaced in the lower uterine segment with the left arm embedded in the myometrium. illustrations: craig zuckerman for obg management 38 OBG Management August 2012

More information

Myanmar and Birth Spacing: An overview

Myanmar and Birth Spacing: An overview Myanmar and Birth Spacing: An overview Background Myanmar is bordered by three of the world s most populous countries: China, India and Bangladesh. The total population of Myanmar is 59.13 million and,

More information

Global Contraception

Global Contraception Video Companion Guide Global Contraception Learning Objectives: By the end of the session, learners will be able to: Describe of all contraceptive methods. Develop a basic understanding of patient-centered

More information

Prescriber Guide for the Letairis REMS Program

Prescriber Guide for the Letairis REMS Program LETAIRIS RISK EVALUATION AND MITIGATION STRATEGY (REMS) Prescriber Guide for the Letairis REMS Program Changes to the Letairis Risk Evaluation and Mitigation Strategy (REMS) Program (November 2018) Revised:

More information

Contraceptive. Ready Lessons II. What Can a Contraceptive Security Champion Do?

Contraceptive. Ready Lessons II. What Can a Contraceptive Security Champion Do? Contraceptive Lesson Security Ready Lessons II Expand client choice and contraceptive security by supporting access to underutilized family planning methods. What Can a Contraceptive Security Champion

More information

4. Timing of post-abortion contraception

4. Timing of post-abortion contraception Web annexes: Medical management of abortion: evidence summary* 4. Timing of post-abortion contraception * This publication forms part of the WHO guideline entitled Medical Management of Abortion. The full

More information